相关实验视频

Updated: Jun 8, 2025

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

Published on: June 15, 2020

粘液穿透生物模拟纳米抗生素用于病原体诱导的肺炎治疗

Yue Wang^1,2, Qihang Ding³, Gongcheng Ma²

¹Cancer Center, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau 999078, China.

|November 1, 2024

概括

新的仿生纳米抗生素克服了肺部粘液障碍,精确地向细菌性肺炎. 这些可追溯的纳米平台,涂有自然杀手 (NK) 细胞膜,增强抗生素的输送和疗效,以改善传染病治疗.

科学领域:

传染性疾病传染性疾病
纳米医学是一种纳米医学.
生物材料是一种生物材料.

背景情况:

细菌性肺炎带来了挑战,因为严重感染的增加和有效的治疗方法有限.
肺部的粘液层阻碍了常规抗生素的输送和有效性.
开发先进的药物输送系统对于克服这些治疗障碍至关重要.

研究的目的:

开发可追溯的生物仿真纳米抗生素 (BioNanoCFPs) 用于增强细菌性肺炎治疗.
为了设计能够穿透肺部粘液并准感染部位的纳米平台.
利用自然杀手 (NK) 细胞膜进行精确的细菌识别和药物输送.

主要方法:

在纳米平台上装载印达二[3,2-b] (ITIC) 和 (CFP).
用自然杀手 (NK) 细胞膜涂层纳米平台,以创建BioNanoCFP.
评估BioNanoCFPs的粘液透能力和细菌向能力.

主要成果:

生物纳米CFPs显示出出色的粘液透性质,有效地到达感染部位.
NK细胞膜促进了与病原体相关的分子模式的识别,使细菌能够精确准.
开发的纳米抗生素实现了针对细菌性肺炎的实质性治疗疗效.

结论:

用NK细胞膜涂层的生物仿真纳米抗生素在细菌性肺炎治疗中有望克服粘液屏障.
通过NK细胞膜介导的药物递送提供了一个可行的策略,用于精确准和增强治疗结果.
这种方法代表了纳米医学在传染病管理方面的重大进步.

关键词:

抗菌疗法:抗菌疗法是一种抗菌疗法.这是一种细菌性肺炎.仿生生物学的仿生学粘液层是一种粘液层.自然杀手细胞是自然杀手细胞.

更多相关视频

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice

Published on: September 28, 2016

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

相关概念视频

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Gene Regulation in Microbial Communities: Quorum Sensing

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Antimicrobial Proteins

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...